Loading...
Loading...
$2.3M
Awarded Jun 24, 2026
Competition
COMPETED UNDER SAP
Offers
2
Set-Aside
None
Solicitation Type
Simplified Acquisition
Performance Timeline
Start
Aug 1, 2026
Estimated start: Jul 31, 2026
Contract: 75N98026P00871
UEI
SB35ENJFKK14
Parent Company
BANNER HEALTH
Capabilities & Certifications
Headquarters Location
Congressional District: 03
Current Obligation
$2,332,200
Base + Exercised Options
$2,332,200
Total Ceiling Value
$6,996,600
Contract Type
FIRM FIXED PRICE
Description
NULISA (A NOVEL PROTEOMIC LIQUID BIOPSY PLATFORM WITH ATTOMOLAR SENSITIVITY AND HIGH MULTIPLEXING) TESTING SERVICES TO IDENTIFY BIOMARKERS THAT PROVIDE INFORMATION ABOUT THE UNDERLYING MOLECULAR CHANGES ASSOCIATED WITH AD/ADRD.
NAICS
TESTING LABORATORIES AND SERVICES
PSC
REFERENCE LABORATORY TESTING
Place of Performance
Congressional District: 08
Awarding Agency
Top-tier Agency
National Institutes of Health
Sub-tier Agency
NATIONAL INSTITUTES OF HEALTH OLAO
Office
Funding Agency
Top-tier Agency
National Institutes of Health
Sub-tier Agency
NATIONAL INSTITUTES OF HEALTH NIA
Office